Effect of Behavior Therapy on Responses to Social Stimuli in People With Social Phobia
This study will evaluate the effect of cognitive behavioral therapy on the brain during emotional and behavioral responses to social stimuli in people with social phobia.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- behavioral: Individual Cognitive Behavioral Therapy
Eligibility
Inclusion Criteria:
- Meets DSM-IV criteria for generalized social phobia
- English-speaking
- Eligible to participate in fMRI scanning
- Willing to use an effective form of contraception throughout the study
Exclusion Criteria:
- Currently undergoing any psychotherapy or pharmacotherapy (e.g, selective serotonin
reuptake inhibitors, benzodiazepines, beta-blockers, anti-psychotics, blood thinners,
thyroid hormone influencing agents, diabetic medications, or anticonvulsants)
- History of neurological or cardiovascular disorders, brain surgery, electroconvulsive
or radiation treatment, brain hemorrhage or tumor, stroke, seizures or epilepsy,
diabetes, hypo- or hyperthyroidism, or head trauma with loss of consciousness for more
than 5 minutes
- Smokes cigarettes daily
- History of or current diagnosis of schizophrenia, schizoaffective disorder, organic
mental disorder, bipolar disorder, or antisocial, schizotypal, or schizoid personality
disorders
- Suicidal thoughts
- Clinically significant and/or unstable medical disease
- Pregnant or breastfeeding
- Alcohol or substance abuse or dependence within the 12 months prior to study entry
- History of or current seizure disorder (except febrile seizure disorder during
childhood)
Ages Eligible for Study
21 Years - 55 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Philippe Goldin
6507235977
Not Recruiting
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.